Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1α (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010 (Q59289154)
Jump to navigation
Jump to search
scientific article published on 01 June 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1α (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010 |
scientific article published on 01 June 1998 |
Statements
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010 (English)
E Marshall
R Powles
M Edwards
L Czaplewski
R Puttick
S Warrington
N Testa
A Millar
M G Hunter
L M Wood
T M Dexter